Biokine – Survival Data from Phase 2a Study of BL-8040 in r/r AML Patients – CBI

Homepage / Press Release / Biokine – Survival Data from Phase 2a Study of BL-8040 in r/r AML Patients

Press Release

Biokine – Survival Data from Phase 2a Study of BL-8040 in r/r AML Patients